CU20130154A7 - THE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF THE ACCESSION, THE PHARMACEUTICAL COMPOSITIONS RELATED TO THE COMPOUND AND THE METHODS FOR THE PREVENTION AND TREATMENT OF ADHERENCES - Google Patents

THE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF THE ACCESSION, THE PHARMACEUTICAL COMPOSITIONS RELATED TO THE COMPOUND AND THE METHODS FOR THE PREVENTION AND TREATMENT OF ADHERENCES

Info

Publication number
CU20130154A7
CU20130154A7 CU2013000154A CU20130154A CU20130154A7 CU 20130154 A7 CU20130154 A7 CU 20130154A7 CU 2013000154 A CU2013000154 A CU 2013000154A CU 20130154 A CU20130154 A CU 20130154A CU 20130154 A7 CU20130154 A7 CU 20130154A7
Authority
CU
Cuba
Prior art keywords
treatment
prevention
compounds
pharmaceutical compositions
adherences
Prior art date
Application number
CU2013000154A
Other languages
Spanish (es)
Inventor
Mikhail Gennadievich Shurygin
Irina Aleksandrovna Shurygina
Original Assignee
Pharmasyntez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2012/052483 external-priority patent/WO2012156938A1/en
Application filed by Pharmasyntez filed Critical Pharmasyntez
Publication of CU20130154A7 publication Critical patent/CU20130154A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere al campo de la farmacia, medicina clínica y experimental y la medicina veterinaria, y en particular, a nuevos compuestos inhibitorios de una p38 MAP quinasa con una estructura del tipo (I)-(VII) que pueden ser utilizados para el tratamiento o la profilaxis de adherencia. La invención da a conocer composiciones farmacéuticas que contienen una cantidad eficaz de la sustancia SB203580 o uno de los compuestos del tipo (I)-(VII) o una combinación de los mismos y un vehículo farmacéuticamente aceptable, un diluyente o un excipiente. También se describe el uso de la sustancia SB203580 como un agente que tiene actividad anti-adherencia. También se describe: un método para la profilaxis y/o tratamiento de una enfermedad o una condición en la cual existe la posibilidad de la formación y/o el crecimiento de las adherencias que hace que sea posible prescindir de la administración adicional de una preparación en el post período de la operación.The invention relates to the field of pharmacy, clinical and experimental medicine and veterinary medicine, and in particular, to new inhibitory compounds of a p38 MAP kinase with a structure of type (I) - (VII) that can be used for the treatment or adhesion prophylaxis. The invention discloses pharmaceutical compositions containing an effective amount of the substance SB203580 or one of the compounds of type (I) - (VII) or a combination thereof and a pharmaceutically acceptable carrier, a diluent or an excipient. The use of the substance SB203580 as an agent having anti-adhesion activity is also described. It is also described: a method for the prophylaxis and / or treatment of a disease or a condition in which there is a possibility of the formation and / or growth of adhesions that makes it possible to dispense with the additional administration of a preparation in The post period of the operation.

CU2013000154A 2011-05-17 2013-11-18 THE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF THE ACCESSION, THE PHARMACEUTICAL COMPOSITIONS RELATED TO THE COMPOUND AND THE METHODS FOR THE PREVENTION AND TREATMENT OF ADHERENCES CU20130154A7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2011119848/15A RU2011119848A (en) 2011-05-17 2011-05-17 METHOD FOR PREVENTION OF SPIKE EDUCATION
PCT/IB2012/052483 WO2012156938A1 (en) 2011-05-17 2012-05-17 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process

Publications (1)

Publication Number Publication Date
CU20130154A7 true CU20130154A7 (en) 2014-05-27

Family

ID=49254499

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2013000154A CU20130154A7 (en) 2011-05-17 2013-11-18 THE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF THE ACCESSION, THE PHARMACEUTICAL COMPOSITIONS RELATED TO THE COMPOUND AND THE METHODS FOR THE PREVENTION AND TREATMENT OF ADHERENCES

Country Status (4)

Country Link
CU (1) CU20130154A7 (en)
MY (1) MY198042A (en)
RU (1) RU2011119848A (en)
UA (1) UA113733C2 (en)

Also Published As

Publication number Publication date
MY198042A (en) 2023-07-27
RU2011119848A (en) 2012-11-27
UA113733C2 (en) 2017-03-10

Similar Documents

Publication Publication Date Title
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
MX2019010354A (en) Heteroaryl[4,3-c]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof.
CL2019002190A1 (en) Reduction of the viscosity of pharmaceutical formulations that comprise a therapeutic protein at a concentration of at least 70 mg / ml, where the therapeutic protein is not an antibody (divisional application 201700984)
AR090456A1 (en) PHARMACEUTICAL COMBINATIONS THAT INCLUDE AN ANALOG OF THIONUCLEOTIDES
MX379155B (en) COMPOUNDS THAT INHIBIT THE MCL-1 PROTEIN.
AR093244A1 (en) SUBSTITUTED BENZENE COMPOUNDS USED IN THE TREATMENT OF EZH2-DISORDERS
ECSP109935A (en) PYRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR PI3K
AR091395A1 (en) AMINOTRIAZOLOPIRIDINE TO USE THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
AR101674A1 (en) USE OF A TRICYCLIC COMPOUND CONTAINING NITROGEN
MX2015012559A (en) NEW HIGH PENETRATION DRUGS AND THEIR COMPOSITIONS FOR THE TREATMENT OF PARKINSON DISEASES.
MX2014002171A (en) COMBINATION TREATMENTS FOR HEPATITIS C.
CO2019007409A2 (en) Tricyclic enone pyrimidin derivatives for rorγ inhibition and other uses
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
CO6231001A2 (en) STABILIZATION OF VITAMIN B12
GT201400059A (en) DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
DOP2016000254A (en) PHARMECEUTIC FORMULATIONS OF PAN-RAF QUINASE INHIBITOR, PROCEDURES FOR THEIR PREPARATION, AND METHODS OF USE.
UY34854A (en) GLUCOSE TRANSPORTATION INHIBITORS
CO2018001700A2 (en) Derivatives of n- [1h-benzimidazol-2-yl] methyl-pyrazin-2-yl-carboxamide, compositions and methods of preparation thereof
MX2016003522A (en) Quinazoline derivatives and their use as dna methyltransferase inhibitors.
PE20181332A1 (en) METHODS OF SEDATION AND PARENTERAL FORMULATION FOR USE DURING THE TREATMENT OF CRITICAL CARE
NI201300124A (en) THE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF ADHESION, THE PHARMACEUTICAL COMPOSITIONS RELATED TO THE COMPOUND AND THE METHODS FOR THE PREVENTION AND TREATMENT OF ADHERENCES.
CO7170181A2 (en) New composition of alfentanil for the treatment of acute pain
PE20130782A1 (en) PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME
CU20130154A7 (en) THE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF THE ACCESSION, THE PHARMACEUTICAL COMPOSITIONS RELATED TO THE COMPOUND AND THE METHODS FOR THE PREVENTION AND TREATMENT OF ADHERENCES
CU20130004A7 (en) THERAPEUTIC AGENTS 976